---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-158327"
form_type: "8-K"
ticker: "RAPP"
cik: "0002012593"
company_name: "Rapport Therapeutics, Inc."
filed_at: "2024-06-10T23:59:59+00:00"
generated_at: "2026-06-01T05:24:30.084572+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Rapport Therapeutics closes private placement of 1,058,824 shares at $17.00 per share with existing stockholders

## Summary
- Entered Stock Purchase Agreements with Sofinnova Venture Partners and affiliates of Goldman Sachs for 1,058,824 shares at $17.00/share, concurrent with IPO.
- Private placement closed June 10, 2024; placement agents included Goldman Sachs, Jefferies, TD Securities, and Stifel.
- Shares issued under Section 4(a)(2) exemption to institutional accredited investors; Sofinnova granted registration rights after one-year anniversary.
- Filed third amended and restated certificate of incorporation and bylaws in connection with IPO effectiveness.

## SEC filing metadata
- accession: 0001193125-24-158327
- form_type: 8-K
- ticker: RAPP
- cik: 0002012593
- company_name: Rapport Therapeutics, Inc.
- filed_at: 2024-06-10T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 3.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2012593/000119312524158327/0001193125-24-158327-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2012593/000119312524158327/d60139d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-158327
- JSON: https://secwatch.observer/filing/0001193125-24-158327.json
- Plain text: https://secwatch.observer/filing/0001193125-24-158327.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.